Comparative effect of ulvan and biosynthesized silver nanoparticles on different cell lines cytotoxicity and gene expression

Amin, Hadear Hanie; Abdel-Reheem or Abdelreheem, Mohammed;

Abstract


Until now, researchers searching for compounds that contribute for treating the most serious disease of this age, cancer. Researchers hope to contribute to this through this research. Activities of both Ulvan extracted from Ulva lactuca and silver nanoparticles (Ag-NPs) were examined against seven different cancer cell types called (Caco2 cells, A549 cells, Mcf7 cells, Hep2 cells, HepG2 cells, PC3 cells, HELA cells). Green synthesized Ag-NPs; via Ulva Lactuca; was characterized by UV-VIS, SEM and TEM. Cell viability assay was conducted to study cytotoxicity effects of both Ulvan and Ag-NPs treatments. RTPCR; using different sense and antisense primers; was carried out to study the expression of GAPDH, Bcl-2, Bax, P21 and P53 (apoptosis related genes) in treated cell lines. SEM and TEM showed that Ag-NPs shape is spherical with average size of 3.89-55 nm. Also, cell viability study showed that both Ulvan and Ag-NPs have cytotoxicity effects on different cancer cells. However, Ag-NPs are more effective than Ulvan. Gene expression data illustrated that both treatments induced down-regulation of Bcl2 and induced up-regulation of P53 genes. This work showed that both Ulvan and Ag-NPs have activities against the investigated cancer cell types.


Other data

Title Comparative effect of ulvan and biosynthesized silver nanoparticles on different cell lines cytotoxicity and gene expression
Authors Amin, Hadear Hanie; Abdel-Reheem or Abdelreheem, Mohammed 
Keywords Biosynthesis | Cancer | Cell Lines | Gene Expression | Silver Nanoparticles | Ulvan
Issue Date 30-Jun-2020
Journal OnLine Journal of Biological Sciences 
ISSN 1608-4217
DOI 10.3844/ojbsci.2020.125.133
Scopus ID 2-s2.0-85087982760

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.